Showing results (2031-2040 of 3,086) with videos related to

Sort By:
Pageof 309
Drug Safety|May 17, 2022
"Artificial Intelligence" for Pharmacovigilance: Ready for Prime Time?Robert Ball, Gerald Dal Pan
Drug Safety|May 17, 2022
Industry Perspective on Artificial Intelligence/Machine Learning in PharmacovigilanceRaymond Kassekert, Neal Grabowski, Denny Lorenz, et al.
Drug Safety|May 17, 2022
Intelligent Telehealth in Pharmacovigilance: A Future PerspectiveHeba Edrees, Wenyu Song, Ania Syrowatka, et al.
Drug Safety|June 1, 2022
Montelukast and Nightmares: Further Characterisation Using Data from VigiBaseSarah Watson, Elenor Kaminsky, Henric Taavola, et al.
Drug Safety|May 23, 2022
Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential InterventionsGiovana R Onzi, Nathalia D'Agustini, Solange C Garcia, et al.
Drug Safety|June 23, 2022
Quantitative Prediction of Adverse Event Probability Due to Pharmacokinetic InteractionsMichel Tod, Thomas Rodier, Marine Auffret
Drug Safety|June 21, 2022
Collection of Data on Adverse Events Related to Medicinal Products: A Survey Among Registries in the ENCePP Resources DatabaseKelly Plueschke, Carla Jonker, Valerie Strassmann, et al.
Drug Safety|June 3, 2021
Monitoring and Managing Lorlatinib Adverse Events in the Portuguese Clinical Setting: A Position PaperFernando Barata, Carlos Aguiar, Tiago Reis Marques, et al.
Drug Safety|November 18, 2020
Changes in Erythropoiesis Stimulating Agent Use Under a Risk Evaluation and Mitigation Strategy (REMS) ProgramAmeet Sarpatwari, Mengdong He, Frazer A Tessema, et al.
Drug Safety|January 31, 2020
Adverse Events in Twitter-Development of a Benchmark Reference Dataset: Results from IMI WEB-RADRJuergen Dietrich, Lucie M Gattepaille, Britta Anne Grum, et al.
Pageof 309